HOME >> BIOLOGY >> NEWS
Prominent North Shore-LIJ physician-researcher brings science to the masses with new book

MANHASSET, NY Though most people have not heard of it, the mysterious and deadly syndrome called severe sepsis is the third leading cause of death for hospitalized patients in the developed world. In the United States, it kills approximately 215,000 people every year, a number exceeded only by heart disease and cancer. While scientific knowledge of severe sepsis has grown in recent years, public awareness remains low. In his new book Fatal Sequence: The Killer Within, Kevin J. Tracey, MD, unravels in terms accessible to the general public the mystery of this silent killer by telling the captivating story of a young patient who changed his life.

A world-renowned physician-scientist who has dedicated his career to studying the inflammatory response and how it can go awry, Dr. Tracey is head of the Susan and Herman Merinoff Center for Patient-Oriented Research at the Institute for Medical Research of the North Shore-Long Island Jewish Health System in Manhasset, NY. He has been credited with initiating a new field of investigation based on therapeutically targeting systemic inflammation. He first outlined his breakthrough work, called "The Inflammatory Reflex," in a January 2003 Nature article (published online in December 2002).

While training to be a neurosurgeon 20 years ago, Dr. Tracey had no idea how dramatically the course of his life would change when a severely burned baby girl was admitted under his care. The infant developed severe sepsis, which ultimately took her life a month later. After the most dramatic physical and emotional roller-coaster ride of Dr. Tracey's life, the recurring nightmares of her death began, and so did his passion to find out what killed her.

He immediately began researching the syndrome and in the process launched his career in biomedical research. Severe sepsis begins when the body's natural immune response to an insult or infection gets so out of control that it starts to impair the functioning of major org
'"/>

Contact: Christina Verni
cverni@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
29-Mar-2005


Page: 1 2

Related biology news :

1. Prominent ecologists to discuss results of worlds largest international ecological meeting
2. Prominent physicist Freeman Dyson to speak at NJIT: Promises and perils of genetic engineering
3. Changing climate will challenge Northeast agriculture, CU expert warns
4. Northern forests less effective than tropical forests in reducing global warming
5. Genomatix expands operations in North America
6. Overfishing great sharks wiped out North Carolina bay scallop fishery
7. Iowa State University botanists identify new species of North American bamboo
8. Climate changes, Cod collapse have altered North Atlantic ecosystems
9. Altered ocean currents disturb ecosystem off Northern California and Oregon coast
10. Hotspots of mercury contamination identified in eastern North America
11. UGA study identifies North American wild bird species that could transmit bird flu

Post Your Comments:
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience technology company ... system, announced today a partnership with eight-time All-Star, ... to develop a new mobile app designed for professional and ... performance. Vision is the inception of every move ... or blocking a pass. The critical impact vision speed has ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, a leader in ... is to open in Manhattan, Kansas in early October, 2015. The location of ... research and development through collaboration with researchers from Kansas State University’s College of ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... 26, 2015 Despite recent ... the optimism in biotech,s forecast is the recent ... sciences advancements.  Active biotechnology & healthcare companies with ... (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: SQNM ), ... Pharmaceutical Corp. (NASDAQ: RPTP ) and EnteroMedics ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
Cached News: